Fluvoxamine-induced intracranial hypertension in a 10-year-old boy

Drug-induced intracranial hypertension is a well-established entity. We report a rare case of intracranial hypertension with papilledema in a 10-year-old boy following use of fluvoxamine, a selective serotonin reuptake inhibitor. On discontinuing the drug, the papilledema resolved over 4 months with...

Descripción completa

Detalles Bibliográficos
Autores principales: Samant, Hemalini, Samant, Preetam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939175/
https://www.ncbi.nlm.nih.gov/pubmed/29676327
http://dx.doi.org/10.4103/ijo.IJO_833_17
_version_ 1783320912139911168
author Samant, Hemalini
Samant, Preetam
author_facet Samant, Hemalini
Samant, Preetam
author_sort Samant, Hemalini
collection PubMed
description Drug-induced intracranial hypertension is a well-established entity. We report a rare case of intracranial hypertension with papilledema in a 10-year-old boy following use of fluvoxamine, a selective serotonin reuptake inhibitor. On discontinuing the drug, the papilledema resolved over 4 months without any residual visual anomalies. To the best of our knowledge, this is the first report of fluvoxamine-induced intracranial hypertension with papilledema.
format Online
Article
Text
id pubmed-5939175
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-59391752018-05-16 Fluvoxamine-induced intracranial hypertension in a 10-year-old boy Samant, Hemalini Samant, Preetam Indian J Ophthalmol Case Reports Drug-induced intracranial hypertension is a well-established entity. We report a rare case of intracranial hypertension with papilledema in a 10-year-old boy following use of fluvoxamine, a selective serotonin reuptake inhibitor. On discontinuing the drug, the papilledema resolved over 4 months without any residual visual anomalies. To the best of our knowledge, this is the first report of fluvoxamine-induced intracranial hypertension with papilledema. Medknow Publications & Media Pvt Ltd 2018-05 /pmc/articles/PMC5939175/ /pubmed/29676327 http://dx.doi.org/10.4103/ijo.IJO_833_17 Text en Copyright: © 2018 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Reports
Samant, Hemalini
Samant, Preetam
Fluvoxamine-induced intracranial hypertension in a 10-year-old boy
title Fluvoxamine-induced intracranial hypertension in a 10-year-old boy
title_full Fluvoxamine-induced intracranial hypertension in a 10-year-old boy
title_fullStr Fluvoxamine-induced intracranial hypertension in a 10-year-old boy
title_full_unstemmed Fluvoxamine-induced intracranial hypertension in a 10-year-old boy
title_short Fluvoxamine-induced intracranial hypertension in a 10-year-old boy
title_sort fluvoxamine-induced intracranial hypertension in a 10-year-old boy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939175/
https://www.ncbi.nlm.nih.gov/pubmed/29676327
http://dx.doi.org/10.4103/ijo.IJO_833_17
work_keys_str_mv AT samanthemalini fluvoxamineinducedintracranialhypertensionina10yearoldboy
AT samantpreetam fluvoxamineinducedintracranialhypertensionina10yearoldboy

Ejemplares similares